[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0506759D0 - Combination treatment methods - Google Patents

Combination treatment methods

Info

Publication number
GB0506759D0
GB0506759D0 GBGB0506759.0A GB0506759A GB0506759D0 GB 0506759 D0 GB0506759 D0 GB 0506759D0 GB 0506759 A GB0506759 A GB 0506759A GB 0506759 D0 GB0506759 D0 GB 0506759D0
Authority
GB
United Kingdom
Prior art keywords
treatment methods
combination treatment
combination
methods
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0506759.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB0506759.0A priority Critical patent/GB0506759D0/en
Publication of GB0506759D0 publication Critical patent/GB0506759D0/en
Priority to PCT/GB2006/001209 priority patent/WO2006106311A2/en
Priority to US11/910,501 priority patent/US20080194666A1/en
Priority to IL186408A priority patent/IL186408A0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0506759.0A 2005-04-02 2005-04-02 Combination treatment methods Ceased GB0506759D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0506759.0A GB0506759D0 (en) 2005-04-02 2005-04-02 Combination treatment methods
PCT/GB2006/001209 WO2006106311A2 (en) 2005-04-02 2006-04-03 Combination treatment methods for treating sex-hormone dependent disease and fertility treatment
US11/910,501 US20080194666A1 (en) 2005-04-02 2006-04-03 Combination Treatment Methods
IL186408A IL186408A0 (en) 2005-04-02 2007-10-07 Combination treatment methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0506759.0A GB0506759D0 (en) 2005-04-02 2005-04-02 Combination treatment methods

Publications (1)

Publication Number Publication Date
GB0506759D0 true GB0506759D0 (en) 2005-05-11

Family

ID=34586629

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0506759.0A Ceased GB0506759D0 (en) 2005-04-02 2005-04-02 Combination treatment methods

Country Status (4)

Country Link
US (1) US20080194666A1 (en)
GB (1) GB0506759D0 (en)
IL (1) IL186408A0 (en)
WO (1) WO2006106311A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
WO2008059213A1 (en) * 2006-11-11 2008-05-22 Ecospray Limited Garlic processing
GB2450082B (en) * 2007-06-11 2011-07-06 Omex Internat Nematode control agent
JP5616233B2 (en) 2008-01-24 2014-10-29 エスペランス ファーマシューティカルズＥｓｐｅｒａｎｃｅ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Lysis domain fusion construct and methods for its generation and use
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP2392323A4 (en) * 2009-01-30 2012-09-26 Univ Kyoto Prostate cancer progression inhibitor and progression inhibition method
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
EP2266567A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2266568A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
EP3871671A3 (en) 2009-07-29 2022-03-09 Olsen, Elise Fp receptor antagonists for inhibiting hair growth
CN101869122A (en) * 2010-06-01 2010-10-27 刘志慧 Garlicin plant growth promoting solution with insect disinfestation and sterilization functions
WO2013025099A1 (en) * 2011-08-17 2013-02-21 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Substrates for the detection of periopathogens of the oral cavity
EP2914633B1 (en) 2012-10-30 2021-12-08 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
WO2018177746A1 (en) * 2017-03-31 2018-10-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) A gnrh antagonist for use in the treatment of a women affected with polycystic ovary syndrome
GB2599620B (en) * 2020-08-04 2023-11-22 Hayne Lane Ltd Ectoparasiticide veterinary composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0986385A4 (en) * 1997-06-05 2001-05-16 Merck & Co Inc Antagonists of gonadotropin releasing hormone
EP1062215A4 (en) * 1998-02-11 2001-03-14 Merck & Co Inc Antagonists of gonadotropin releasing hormone
CA2428249A1 (en) * 2000-11-16 2002-05-23 Pharmacia & Upjohn Company Combination therapy for estrogen-dependent disorders
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation

Also Published As

Publication number Publication date
WO2006106311A3 (en) 2006-12-21
WO2006106311A2 (en) 2006-10-12
US20080194666A1 (en) 2008-08-14
IL186408A0 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
IL186408A0 (en) Combination treatment methods
IL183889A0 (en) Treatment method
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
IL191379A (en) Sewage treatment
GB0600692D0 (en) Well treatment
ZA200704610B (en) Treatment apparatus
EP1858587A4 (en) Aesthetic treatment device
ZA200709627B (en) Combination therapy
IL184330A0 (en) Treatment apparatus
GB0504206D0 (en) Combination therapy
MY143527A (en) Wood treatment
GB0509052D0 (en) Combination therapy
GB0516068D0 (en) Well treatment
GB2430002B (en) Well treatment
GB0511769D0 (en) Treatment
GB0525540D0 (en) New treatment
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
GB0502171D0 (en) Well treatment
GB0525535D0 (en) Tumour treatment
GB2421946B (en) Water treatment
GB0412411D0 (en) Treatment
GB0513791D0 (en) Treatment device
GB0413584D0 (en) Well treatment
GB0513778D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)